References
- Liu, Y.J., Johnson, G.D., Gordon, J. and Maclennan, IC. (1992) "Germinal centres in T-cell-dependent antibody responses", Immunol. Today 13, 17–21.
- Manz, R.A., Thiel, A. and Radbruch, A. (1997) "Lifetime of plasma cells in the bone marrow", Nature 388, 133–134.
- McHeyzer-Williams, M.G. and Ahmed, R. (1999) "B cell memory and the long-lived plasma cell", Curr. Opin. Immunol. 11, 172–179.
- Kawano, M.M., Mihara, K., Tsujimoto, T., Huang, N. and Kuramoto, A. (1995) "A new phenotypic classification of bone marrow plasmacytosis", Int. J. Hematol. 61, 179–188.
- Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y, Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. and Kishimoto, T. (1988) "Autocrine generation and require-ment of BSF-2 /IL-6 for human multiple myelomas", Nature 332, 83–85.
- Kawano, M.M., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., Iwato, K. and Kuramoto, A. (1993) "Identification of immature and mature myeloma cells in the bone marrow of human myelomas", Blood 82, 564–570.
- Ishikawa, H., Mahmoud, US., Fujii, R., Abroun, S. and Kawano, UM. (2000) "Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma", Leuk. Lymphoma 39, 51–55.
- Fujii, R., Ishikawa, H., Mahmoud, MS., Asaoku, H. and Kawano, M.M. (1999) "MPC-1-CD49e- immature myeloma cells include CD45 + subpopulations that can proliferate in response to IL-6 in human myelomas", Br. J. Haematol. 105, 131–140.
- Mahmoud, MS., Ishikawa, H., Fujii, R. and Kawano, M.M. (1998) "Induction of CD45 expression and proliferation in U-266 myeloma cell line by interleukin-6", Blood 92, 3887–3897.
- Tsuyama, N., Ishikawa, H., Abroun, S., Liu, S., Li, F.-J. and Kawano, MM. (2001) "The proliferation of MPC-1- CD49e-CD45+ immature myeloma cells are strictly controlled by IL-6 in the SCID-hIL6 Tg mice", Blood 98, 632a.
- Ishikawa, H., Tsuyama, N., Abroun, S., Liu, S., Li, F.J., Taniguchi, O. and Kawano, M.M. (2002) "Requirements of src family kinase activity associated with CD45 for myeloma cell proliferation by interleukin-6", Blood 99, 2172–2178.
- Abroun, S., Ishikawa, H., Tsuyama, N., Liu, S., Li, F.-J. and Kawano, M.M. (2001) "Insulin and IGF-1 are survival factors for myeloma cells in vitro", Blood 98, 639a.
- Chesi, M., Brents, L.A., Ely, S.A., Bais, C., Robbiani, D.F., Mesri, E.A., Kuehl, W.M. and Bergsagel, P.L. (2001) "Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma", Blood 97, 729–736.
- Qiu, Y., Ravi, L. and Kung, H.J. (1998) "Requirement of ErbB2 for signalling by interleuldn-6 in prostate carcinoma cells", Nature 393, 83–85.